Evidence map›Paper›PMID 24513978›Full record

ArticleScientific reports2014

Src tyrosine kinase signaling antagonizes nuclear localization of FOXO and inhibits its transcription factor activity.

Margret H Bülow, Torsten R Bülow, Michael Hoch, Michael J Pankratz, Martin A Jünger

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. The link of FOXO1 and FOXO4 transcription factors to development of the lens.Developmental dynamics : an official publication of the American Association of Anatomists · 2025
    Article
  2. Review
  3. A coherent FOXO3-SNAI2 feed-forward loop in autophagy.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Margret H Bülow1] Institute of Molecular Systems Biology, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland [2] Life and Medical Sciences (LIMES) Institute, Program Unit Development and Genetics, Laboratory for Molecular Developmental Biology, University of Bonn, 53115 Bonn, Germany.
Torsten R BülowLife and Medical Sciences (LIMES) Institute, Department of Molecular Brain Physiology and Behavior, University of Bonn, 53115 Bonn, Germany.
Michael HochLife and Medical Sciences (LIMES) Institute, Program Unit Development and Genetics, Laboratory for Molecular Developmental Biology, University of Bonn, 53115 Bonn, Germany.
Michael J PankratzLife and Medical Sciences (LIMES) Institute, Department of Molecular Brain Physiology and Behavior, University of Bonn, 53115 Bonn, Germany.
Martin A JüngerInstitute of Molecular Systems Biology, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland.
ETH Zurich · CHUniversity of Bonn · DELife & Brain (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biochemical experiments in mammalian cells have linked Src family kinase activity to the insulin signaling pathway. To explore the physiological link between Src and a central insulin pathway effector, we investigated the effect of different Src signaling levels on the Drosophila transcription factor dFOXO in vivo. Ectopic activation of Src42A in the starved larval fatbody was sufficient to drive dFOXO out of the nucleus. When Src signaling levels were lowered by means of loss-of-function mutations or pharmacological inhibition, dFOXO localization was shifted to the nucleus in growing animals, and transcription of the dFOXO target genes d4E-BP and dInR was induced. dFOXO loss-of-function mutations rescued the induction of dFOXO target gene expression and the body size reduction of Src42A mutant larvae, establishing dFOXO as a critical downstream effector of Src signaling. Furthermore, we provide evidence that the regulation of FOXO transcription factors by Src is evolutionarily conserved in mammalian cells.

Indexed as

AnimalsCell NucleusDrosophilaDrosophila ProteinsForkhead Box Protein O3Forkhead Transcription FactorsIndolesIntracellular Signaling Peptides and ProteinsLarvaMiceNIH 3T3 CellsPeptide Initiation FactorsPhenotypeProto-Oncogene Proteins pp60(c-src)Receptor, InsulinSignal TransductionDrosophila ProteinsForkhead Box Protein O3Forkhead Transcription FactorsFoxO3 protein, mouseFOXO protein, DrosophilaIndolesIntracellular Signaling Peptides and ProteinsPeptide Initiation FactorsProto-Oncogene Proteins pp60(c-src)Receptor, InsulinSrc42A protein, Drosophilasrc-Family KinasesSU 6656SulfonamidesThor protein, Drosophila

Identifiers

PMID24513978
PMCPMC3920272
OpenAlexW2061397247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.